首页> 外文期刊>BMC Nephrology >Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene
【24h】

Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene

机译:西班牙大型家庭的Alport综合征的表型变异与COL4A3基因的新突变相关

获取原文
           

摘要

Alport syndrome is an inherited renal disorder characterized by glomerular basement membrane lesions with hematuria, proteinuria and frequent hearing defects and ocular abnormalities. The disease is associated with mutations in genes encoding α3, α4, or α5 chains of type IV collagen, namely COL4A3 and COL4A4 in chromosome 2 and COL4A5 in chromosome X. In contrast to the well-known X-linked and autosomal recessive phenotypes, there is very little information about the autosomal dominant. In view of the wide spectrum of phenotypes, an exact diagnosis is sometimes difficult to achieve. We investigated a Spanish family with variable phenotype of autosomal dominant Alport syndrome using clinical, histological, and genetic analysis. Mutational analysis of COL4A3 and COL4A4 genes showed a novel heterozygous mutation (c. 998G?>?A; p.G333E) in exon 18 of the COL4A3 gene. Among relatives carrying the novel mutation, the clinical phenotype was variable. Two additional COL4A3 mutations were found, a Pro-Leu substitution in exon 48 (p.P1461L) and a Ser-Cys substitution in exon 49 (p.S1492C), non-pathogenics alone. Carriers of p.G333E and p.P1461L or p.S1492C mutations in COL4A3 gene appear to be more severely affected than carriers of only p.G333E mutation, and the clinical findings has an earlier onset. In this way, we could speculate on a synergistic effect of compound heterozygosity that could explain the different phenotype observed in this family.
机译:Alport综合征是一种遗传性肾脏疾病,其特征是肾小球基底膜病变伴血尿,蛋白尿和频繁的听力缺陷和眼部异常。该疾病与编码IV型胶原的α3,α4或α5链的基因突变有关,即2号染色体上的COL4A3和COL4A4,以及X染色体上的COL4A5。与众所周知的X连锁和常染色体隐性表型相反,关于常染色体显性遗传的信息很少。考虑到广泛的表型,有时很难实现准确的诊断。我们使用临床,组织学和遗传学分析调查了常染色体显性遗传阿尔波特综合征表型可变的西班牙家庭。对COL4A3和COL4A4基因的突变分析表明,在COL4A3基因的外显子18上有一个新的杂合突变(c。998G→> A; p.G333E)。在携带新突变的亲属中,临床表型是可变的。发现了另外两个COL4A3突变,第48外显子中的Pro-Leu取代(p.P1461L)和第49外显子中的Ser-Cys取代(p.S1492C),仅是非致病性的。与仅具有p.G333E突变的载体相比,COL4A3基因中的p.G333E和p.P1461L或p.S1492C突变的载体似乎受到的影响更大,而且临床发现的起步较早。通过这种方式,我们可以推测化合物杂合性的协同作用可以解释该家族中观察到的不同表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号